Disc Medicine (IRON) Retained Earnings (2020 - 2026)
Disc Medicine's (IRON) quarterly Retained Earnings came in at $1.3 billion in Q1 2026, up 27.3% year-on-year from $991.9 million in Q1 2025, and up 1.09% on a QoQ basis from $1.2 billion in Q4 2025.
Disc Medicine (IRON) Retained Earnings (2020 - 2026) Analysis & Trends
Disc Medicine (IRON) has 7 years of Retained Earnings data on file, last reported at $1.3 billion in Q1 2026.
- On a quarterly basis, Retained Earnings rose 27.3% year-over-year to $1.3 billion in Q1 2026; TTM through Mar 2026 was $1.3 billion, a 27.3% increase from a year earlier, with the FY2025 full-year figure at $1.2 billion, up 519.14% from the prior year.
- Retained Earnings for Q1 2026 stood at $1.3 billion, up from $1.2 billion in the prior quarter.
- Over the last five years, Retained Earnings for IRON reached as high as $1.3 billion in Q1 2026 and fell as low as -$449.7 million in Q3 2025.
- Historically, Retained Earnings has averaged $221.6 million across 5 years, with a median of -$143.0 million in 2023.
- On a YoY basis, Retained Earnings climbed as much as 541.69% in 2022 and fell as far as 167.65% in 2022.
- Year by year, Retained Earnings stood at $288.8 million in 2022, then plunged by 157.15% to -$165.1 million in 2023, then plunged by 80.54% to -$298.0 million in 2024, then soared by 519.14% to $1.2 billion in 2025, then advanced by 1.09% to $1.3 billion in 2026.
- Per Business Quant data, the three most recent Retained Earnings figures were $1.3 billion in Q1 2026, $1.2 billion in Q4 2025, and -$449.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Disc Medicine | 2.90 Bn | 2.90 Bn | - | 1.26 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.26 Bn |
| Dec 31, 2025 | 1.25 Bn |
| Sep 30, 2025 | -449.66 Mn |
| Jun 30, 2025 | 1.00 Bn |
| Mar 31, 2025 | 991.91 Mn |
| Dec 31, 2024 | -298.00 Mn |
| Sep 30, 2024 | -268.55 Mn |
| Jun 30, 2024 | -241.90 Mn |
| Mar 31, 2024 | 553.66 Mn |
| Sep 30, 2023 | -165.07 Mn |
| Jun 30, 2023 | -150.94 Mn |
| Mar 31, 2023 | -135.00 Mn |
| Dec 31, 2022 | 288.81 Mn |
| Sep 30, 2022 | 314.85 Mn |
| Jun 30, 2022 | -207.01 Mn |
| Mar 31, 2022 | -199.92 Mn |
| Dec 31, 2021 | -65.39 Mn |
| Sep 30, 2021 | -166.87 Mn |
| Jun 30, 2021 | 305.99 Mn |
| Mar 31, 2021 | 303.03 Mn |